GIACOMO CHIARO LTD

Executive Summary

GIACOMO CHIARO LTD is a small, active healthcare-related private limited company with a stable and improving financial position as evidenced by positive net assets and timely statutory filings. The company currently operates with minimal cash and relies on director loans, which should be reviewed for liquidity risk. Overall, the company presents a low risk profile, though further inquiry into its operational business model and funding arrangements is recommended to confirm ongoing sustainability.

GIACOMO CHIARO LTD - Analysis Report

Company Number: 14403225

Analysis Date: 2025-07-29 20:26 UTC

1. Risk Rating: LOW
   The company shows a positive net asset position with no overdue filings, minimal liabilities, and no indication of operational distress. The financials are straightforward, and compliance is up to date.

2. Key Concerns:

• The current liabilities are solely director loans (£6,461), which may indicate reliance on director funding rather than external financing; though not inherently negative, it warrants monitoring for potential cash flow dependency.
• Cash balances remain very low (£2,066 in 2024), which could constrain liquidity if operational expenses increase or revenue generation lags.
• The company has no employees, suggesting operations may be limited or reliant on the director and possibly outsourcing; this may affect scalability and operational continuity.

3. Positive Indicators:

• The company is active and has filed all statutory accounts and confirmation statements on time, indicating good regulatory compliance.
• Net assets have increased from £1,036 in 2023 to £8,527 in 2024, reflecting an improving financial position.
• The shareholder (and director) holds 75-100% control and is professionally identified as a doctor, which aligns with the health care SIC codes and might imply relevant expertise and commitment.
• The company benefits from exemption from audit under small company rules, consistent with its size and financial scale.

4. Due Diligence Notes:

• Investigate the nature and terms of the director loan to understand repayment expectations and impact on future cash flows.
• Confirm the company’s revenue streams, business model, and whether it has contracts or patients to ensure operational viability beyond cash balances.
• Review any contingent liabilities or off-balance-sheet exposures not captured in the filed accounts.
• Assess the plans for business growth or employee hiring to evaluate sustainability and operational risk.
• Verify the absence of adverse regulatory issues or director disqualifications beyond what is publicly available.